WSJ: They got cancer, and then their drugs were rationed
University of Cincinnati Cancer Center physician discusses chemotherapy shortage
Across the U.S., a monthslong shortage of critical chemotherapies have forced doctors and pharmacists to stretch their supplies, according to an article in the Wall Street Journal.
Some patients have received less treatment or lengthened the time between treatments, while others have had to turn to second-line options.
The chemotherapies in shortage are cheap, generic drugs that don’t make much profit —and few companies want to manufacture them. After the Food and Drug Administration found quality problems late last year at a major manufacturing facility in India, the company halted its production of two of these drugs, cisplatin and carboplatin, sparking the scarcity.
These (drugs) are the backbones of treatment for many of these cancers, and it is frustrating that this is where we are.
Davendra Sohal University of Cincinnati Cancer Center
At least two dozen patients at the University of Cincinnati Cancer Center have had their treatment disrupted, said Davendra Sohal, MD, an oncologist who treats gastrointestinal cancer patients; he is associate director of clinical research at the Cancer Center. Those already in clinical trials or who can be cured take priority when rationing the drugs, he said, followed by those with progressing disease.
Some patients who are dealing with more stable, chronic disease have had to miss a dose in order to manage the supply, he added. A patient who travels weekly from West Virginia for treatment made the trip last month to find out that there wasn’t any drug, Sohal said. A few weeks ago, only half of the colorectal cancer patients could get their scheduled dose.
“The other half we called and said sorry, not this week,” Sohal said. “These are the backbones of treatment for many of these cancers, and it is frustrating that this is where we are.”
Read the full Wall Street Journal story.
Learn more about the University of Cincinnati Cancer Center.
Featured image at top of Davendra Sohal. Photo credit/UC Health
Innovation Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
6 ways starting a GLP-1 medication could affect your emotions
May 20, 2026
When patients first start taking a glucagon-like peptide-1 (GLP-1) medication, they probably expect to feel full. But they might not anticipate how it can influence their emotions. The medications act on the stomach and the brain, said Malti Vij, MD, a University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine and a diplomate of the American Board of Obesity Medicine.
UC researchers recruit older adults for extreme heat health study
May 20, 2026
The University of Cincinnati’s Center for Collaboration on Climate & Community for Health (C4H) is recruiting older adults to participate in a study tracking their health during periods of extreme summer heat.
$15 million bequest supports endowed chair at UC College of Medicine
May 19, 2026
As a student and resident at the University of Cincinnati College of Medicine, George G. Bemis, Jr., MD, Med ’64, saw firsthand that medicine was more than a profession for those teaching and leading him. Inspired by their sense of calling, he knew he wanted to pursue the same path.